Original Article

• Evaluation of the Safety and Efficacy of SOF/VEL Treatment and Pre-treatment of TAF in Patients with Chronic Hepatitis B Virus/Hepatitis C Virus Coinfection: A Multicenter Study

  Yifan Han, Ning Lin, Dazhi Zhang, Zuxiong Huang, Minghua Su, Jiawei Geng, Zhili Wen, Songsong Xie, Xiaobo Lu, Hong You, Liting Zhang, Jia Shang, Liaoyun Zhang, Yuemin Nan, Biao Wu, Chengzhen Lu, Ying’an Jiang, Qian Kang, Hongyu Chen, Zhan Zeng, Yanyan Yu, Xiaoyuan Xu

  

• GSTM3 Knockdown Promotes Liver Fibrosis Reversal by Inhibiting Hepatic Stellate Cell Activation via PPARγ Signaling

  Chenxue Hou, Bingqing Yang, Yuanying Zhao, Hao Chang, Tong Bu, Qi Wang, Yue Li

  

• A Dual Time Window-driven Strategy to Optimize Primary Biliary Cholangitis Treatment via Alkaline Phosphatase Normalization

  Han Zhao, Yansheng Liu, Yingmei Tang, Ningning Wang, Yanmin Liu, Yiling Li, Chunyang Huang, Jieting Duan, Yan Feng, Linhua Zheng, Ruiqing Sun, Xiufang Wang, Juan Deng, Gui Jia, Patrick S.C. Leung, M. Eric Gershwin, Yulong Shang, Ying Han

  
• A Multi-omics and Machine Learning Framework Identifies Plasma SBDS as a Causal Biomarker and Therapeutic Target in Primary Sclerosing Cholangitis

  Pengfei Cheng, Yuanming Qiang, Yibo Sun, Binwei Duan, Yabo Ouyang, Guangming Li

  

Review Article

• Reducing the Risk of Overt Hepatic Encephalopathy Recurrence: A Narrative Review

  Nikolaos T. Pyrsopoulos, Nadege Gunn, Prasun K. Jalal, George E. Catinis

  
• Short-chain Fatty Acids and Bile Acids Signaling in Chronic Hepatitis B

  Siqi Sun, Sisi Yang, Yihe Yu, Jiyang Chen, Jintao Ning, Yida Yang, Hongyu Jia

  

Letter to the Editor

• Letter to the Editor: Genotype-specific Response to 144-week Entecavir Therapy for HBeAg-positive Chronic Hepatitis B with a Particular Focus on Histological Improvement: A Prospective Study

  Chenhao Ye, Lei Wang